Signals, Powered By EquityPandit
The USFDA has provided its tentative approval to Glenmark Pharmaceuticals for Milnacipran Hydrochloride tablets.
It has said in a BSE filing that “Glenmark Pharmaceuticals Inc, USA, has been granted tentative approval by the United States Food and Drug Administration (USFDA) for Milanacipran Hydrochloride tablets, 12.5 mg, 25 mg, 50 mg and 100 mg.”
Milnacipran Hydrochloride tablets are a generic version of Savella drug, 12.5 mg, 25 mg, 50 mg and 100 mg of Allergan Sales LLC.
